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From Proof-of-Concept Material to PEGylated and Modularly 
Targeted Ultrasound-Responsive Mesoporous Silica 
Nanoparticles.  
Juan L. Paris
a,b
, Gonzalo Villaverde
a,b
, M. Victoria Cabañas
a
, Miguel Manzano
a,b
 and María Vallet-
Regí
a,b,
* 
In this work we present the synthesis, characterization and in vitro biological evaluation of PEGylated and actively-targeted 
ultrasound-responsive hybrid mesoporous silica nanoparticles. This work covers the development of the chemical 
strategies necessary to afford a modular nanocarrier starting from a proof-of-concept material presented in previous 
work. This functional ultrasound-responsive material can be adapted to different specific pathological conditions by 
carefully choosing the appropriate targeting moieties. The new ultrasound responsive material is able to target HeLa cells 
when conjugated with biotin or an RGD peptide. Ultrasound-responsive cytotoxicity towards cancer cells of doxorubicin-
loaded nanoparticles is demonstrated in an in vitro cytotoxicity assay. 
Introduction  
Nanomedicine, the use of nanotechnology to diagnose or treat 
different pathologies, holds great promise to improve patient 
care.
1
 Almost 75% of nanomedicines in clinical use consist of 
nanoparticles for drug delivery,
2
 in which the main rationale is 
their capacity to improve the pharmacokinetics of the drug. 
Nanocarriers can enhance the stability and circulation time of 
the drug, increasing the amount that reaches the target organ 
and, therefore, decreasing the toxicity of chemotherapeutic 
drugs
1
. In the context of cancer, nanoparticles are able to 
reach tumor tissues due to the enhanced permeation and 
retention (EPR) effect.
3
 The EPR effect is based on an increased 
extravasation of nanoparticles and macromolecules into the 
tumor due to leaky vasculature in the area, coupled with a 
decreased withdrawal capacity caused by the collapse of 
lymphatic vessels in solid tumors. Decorating the nanoparticle 
surface with polyethylene glycol (PEG) chains, in a process so-
called PEGylation, inhibits protein adsorption on the 
nanoparticle surface. This hinders its recognition by 
macrophages and increases their circulation time in the 
bloodstream. This allows more nanoparticles to reach the 
tumor site. Additionally, active targeting strategies have also 
been developed by decorating the surface of nanocarriers with 
molecules that will induce their selective internalization in 
cancer cells.
4
 This active targeting has been shown to increase 
the therapeutic efficacy of nanomedicines.
4
 
In recent years, stimuli-responsive nanomaterials have 
attracted great attention in the context of cancer treatment.
5
 
The possibility of inducing drug release only in the diseased 
site could potentially improve the efficacy of nanotherapeutics 
while decreasing the side-effects of systemic administration of 
anticancer drugs. Both internal (like pH or redox)
6,7
 and 
external (like light, magnetic field and ultrasound)
8–18
 stimuli 
have been widely studied. However, ultrasound (US) appears 
especially interesting due to its non-invasiveness and high 
penetration capacity in living tissues. US offers the possibility 
to focus high frequency ultrasound deep into the body and the 
tumor mass, which would avoid unnecessary exposure to 
surrounding healthy tissues.
10
 
Mesoporous Silica Nanoparticles (MSNs) have also attracted 
much attention as drug carriers due to their high 
physicochemical stability and textural properties that would 
allow a high drug loading capacity.
19–23
 In our group, we have 
recently reported an US-responsive MSN-based drug 
nanocarrier as an efficient proof of concept system for on-
demand drug delivery.
24
 However, the material presented in 
our previous work lacked some of the necessary characteristics 
needed for its use in a therapeutic application. For example, 
the surface of the material at physiological temperature is 
highly hydrophobic and the particles tend to aggregate. The 
lack of a PEG layer and active targeting moieties would also 
prevent them from reaching the desired target cancer 
cells.
25,26
The objective of this work is to adapt our previous 
proof-of-concept material to a more viable design, according 
to the current knowledge in the field. Consequently, a series of 
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chemical strategies were here developed to synthesize a 
PEGylated and modularly targeted US-responsive 
nanomaterial. 
Experimental 
Materials. 
The following compounds were purchased from Sigma-Aldrich, 
and were used without further purification: ammonium 
nitrate, tetraethyl orthosilicate (TEOS), pyridine, methacrylic 
acid (MAA), (3-aminopropyl)triethoxysilane (APTES), 
cetyltrimethylammonium bromide (CTAB), fluorescein 
isothiocyanate (FITC), p-toluenesulfonic acid, dichloromethane 
(DCM), dihydropyran (DHP), dibenzocyclooctyne-amine 
(DBCO-amine), dimethylformamide (DMF), 2-(2-
methoxyethoxy) ethyl methacrylate (MEO2MA), 4,4’-azobis(4-
cyanovaleric acid) (ABCVA), diethyl ether, hexylamine, N-
hydroxysuccinimide (NHS), N,N-diisopropylethylamine (DIPEA), 
4-cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic 
acid (CDTPA), triethylamine (TEA), N,N’-
dicyclohexylcarbodiimide (DCC), phosphate-buffered saline 
(PBS), methoxypolyethylene glycol maleimide (MAL-PEG-
OMe), toluene, poly(ethylene glycol) [N-(2-
maleimidoethyl)carbamoyl]ethyl ether 2-
(biotinylamino)ethane average Mn 3800 Da (MAL-PEG-BIOTIN), 
poly(ethylene glycol) (N-hydroxysuccinimide 5-pentanoate) 
ether N′-(3-maleimidopropionyl)aminoethane average Mn 
4000 Da (MAL-PEG-NHS), 4-hydroxyazobenzene-2-carboxylic 
acid (HABA)/avidin kit, doxorubicin and fluorescein sodium 
salt. TetramethylrhodamineAzide (TAMRA-N3) was purchased 
from Thermo Fisher Scientific, and used without further 
purification. Dulbecco's Modified Eagle's Medium (DMEM), 
penicillin–streptomycin, and trypsin–EDTA were purchased 
from Invitrogen (Fisher Scientific, Spain). Fetal bovine serum 
(FBS) was purchased from Biowest (Labclinics, Spain). 
Characterization techniques. 
Characterization of the materials used in this study was 
performed by the following techniques: thermogravimetry and 
differential thermal analysis (TGA/DTA) in a PerkinElmer Pyris 
Diamond TG/DTA analyzer, with 10 ºC/min heating ramps, 
from 25 ºC to 600 ºC. Fourier transform infrared (FTIR) spectra 
were obtained in a Nicolet Nexus spectrometer (Thermo Fisher 
Scientific) equipped with a Smart Golden Gate attenuated total 
reflectance (ATR) accessory. Transmission electron microscopy 
(TEM) was carried out in a JEOL JEM 2100 instrument operated 
at 200 kV, equipped with a CCD camera (KeenView Camera). 
Phosphotungstic acid (PTA) was used to stain organic matter in 
the hybrid materials. N2 adsorption was carried out on a 
Micromeritics ASAP 2010 instrument; surface area was 
obtained by applying the Brunauer–Emmett–Teller (BET) 
method to the isotherm and the pore size distribution was 
determined by the Barrett–Joyner–Halenda (BJH) method from 
the desorption branch of the isotherm. Mesopore diameter 
was obtained from the maximum of the pore size distribution 
curve. Z potential and hydrodynamic size of nanoparticles by 
Dynamic Light Scattering (DLS) were measured by means of a 
Zetasizer Nano ZS (Malvern Instruments) equipped with a 633 
nm “red” laser. 
1
H Nuclear Magnetic Resonance (NMR) 
experiments were carried out in a Bruker AV 250 MHz 
apparatus. Mass spectra were acquired with a Voyager DE-STR 
Biospectrometry Matrix-Assisted Laser Desorption/Ionization-
Time Of Flight (MALDI-TOF) mass spectrometer. To determine 
the molecular weight distribution of the copolymers, Gel 
Permeation Chromatography (GPC) was performed in a Waters 
Alliance automatic analysis system with a Model #2695 
separations module coupled to a Model #2414 Refractive 
Index Detector. GPC measurements were carried out using 
polyethylene (Glycol/ Oxide) standards and DMF with LiCl 10 
mM as the eluent.  
The Lower Critical Solution Temperature (LCST) of the 
polymers was determined by DLS by means of the drastic 
change in the scattering intensity obtained by the precipitation 
of the polymer at the LCST (determined as the temperature at 
which the scattering intensity is 50 % of the maximum). To 
determine the transition temperature, the temperature 
dependence of the scattering intensity of a polymer solution 
was measured. The temperature was increased by discrete 
temperature increments in the range 10-45 ºC. 
Fluorescence spectrometry was used to determine cargo 
release by means of a Biotek Synergy 4 device. Fluorescence 
microscopy was performed in an Evos FL Cell Imaging System 
equipped with tree Led Lights Cubes (λEx (nm); λEm (nm)): DAPI 
(357/44; 447/60), GFP (470/22; 525/50), RFP (531/40; 593/40) 
from AMG (Advance Microscopy Group). Quantitative analysis 
of cellular uptake was performed by flow cytometry in a BD 
FACSCalibur™ cytometer, and results were processed using 
Flowing Software. 
Preparation of PEGylated Ultrasound-Responsive system. 
Synthesis of Mesoporous Silica Nanoparticles. 
MSNs were synthesized by a condensation reaction of TEOS in 
the presence of CTAB template under dilute, basic conditions, 
as described elsewhere.
24
 FITC-labeled MSNs were synthesized 
by reacting 1 mg of FITC with 2.2 μL APTES in 100 μL ethanol 
for 2 h. Then, the reaction mixture was added with TEOS to 
obtain the FITC-labeled MSNs, following the same protocol as 
before. 
Synthesis of Ultrasound-Responsive Copolymer. 
The monomer tetrahydropyranyl methacrylate (THPMA) was 
synthesized and purified as previously described.
24,27
 
The random copolymer poly(2-(2-methoxyethoxy) ethyl 
methacrylate-co-2-tetrahydropyranyl methacrylate), with two 
functional ends and a monomer ratio 90:10 
(MEO2MA:THPMA), was obtained by Reversible Addition-
Fragmentation Chain Transfer (RAFT) polymerization, adding 
CDTPA, ABCVA, MEO2MA and THPMA in a Schlenk flask. The 
flask was purged with N2 and 8 mL dry DMF were added, with 
a catalytic amount of DIPEA to protect THPMA from 
degradation during the synthesis. Then, the flask was 
deoxygenated by three freeze-pump-thaw cycles. The reaction 
mixture was placed at 80 ºC under N2 overnight with magnetic 
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stirring. The obtained polymer was then precipitated and 
washed with diethyl ether. During synthesis optimization, 
different monomers/CDTPA ratios (Table S1) were used to 
obtain US-responsive polymers (PUS, Figure 1) with different 
molecular weights. Depending on the length of the polymers, 
each specific sample was named as follows: ca. 25000 Da 
(small, PUSS), ca. 50000 Da (medium, PUSM) and ca. 70000 Da 
(large, PUSL). The synthesized polymers presented yellow color 
due to the presence of the trithiocarbonate group from the 
RAFT agent, which confirmed the integrity of CDTPA through 
the polymerization reaction.
28,29
 
Preparation of PEGylated Ultrasound-Responsive Copolymer. 
PEGylation of the obtained RAFT random copolymers was 
carried out by reacting MAL-PEG-OMe with the copolymer 
after the aminolysis of the trithiocarbonate group from CDTPA, 
which gives rise to a thiol moiety that reacted with the 
maleimide through a thiol-ene click reaction. This was 
performed as a one-pot reaction, by adding the MAL-PEG-OMe 
to the solution where the aminolysis was going to take place. 
Three PUS-PEG samples were obtained, PUSS-PEG, PUSM-PEG 
and PUSL-PEG, depending on the PUS used. The conditions to 
obtain PUSL-PEG were: 500 mg of PUSL and 100 mg of MAL-
PEG-OMe were dissolved in 14 mL of dry DMF under inert 
atmosphere. The solution was deoxygenated by bubbling N2. 
Then, 500 µL of dry DMF containing 5 µL of hexylamine and 5 
µL of TEA were added (to obtain PUSM-PEG and PUSS-PEG, the 
amount of MAL-PEG-OMe, hexylamine and TEA were adjusted 
to keep the same molar ratios as described above). The 
reaction took place overnight at room temperature, under N2 
and with magnetic stirring. Then, the polymers were 
precipitated in diethyl ether. After evaporating the ether, the 
solid was dissolved in ice-cold water. After heating the solution 
to 50 ºC, the precipitate formed was centrifuged and washed 
with preheated water. The purified polymer was then freeze-
dried to obtain PUS-PEG.  
Grafting PEGylated Ultrasound-Responsive Copolymer to MSNs. 
Polymer grafting on the surface of MSNs to obtain HYBRID-PEG 
was performed as described previously.
24
 Depending on the 
molecular weight of the polymeric gate being grafted, three 
different materials were obtained: HYBRIDS-PEG, HYBRIDM-PEG 
and HYBRIDL-PEG. To prepare HYBRIDL-PEG, 200 mg of PUSL-
PEG were conjugated with APTES (5 µL) using DCC (4 mg) and 
NHS (2 mg) under N2 in 3 mL dry DMF at room temperature, 
overnight, under magnetic stirring. Then, this sililated 
copolymer was reacted with previously dispersed MSNs (35 
mg) in toluene at 80 ºC, overnight. The addition of the polymer 
to the MSNs suspension in toluene was performed in three 
steps, leaving 4 h gaps between additions to prevent polymer-
to-polymer condensation. The hybrid nanoparticles so 
obtained, HYBRIDL-PEG, were then collected by centrifugation 
and washed with toluene, DMF (3 times), cold water (3 times) 
and ethanol. Then, the nanoparticles were dried under 
vacuum. To obtain HYBRIDM-PEG and HYBRIDS-PEG, the 
amount of APTES, DCC and NHS were adjusted to keep the 
same molar ratios as used above. 
Preparation of Actively-targeted PEGylated Ultrasound-
Responsive system. 
Synthesis of Biotin-targeted nanoparticles. 
The polymer PUSL-PEG-BIOTIN was synthesized in a similar way 
to the one described for PUS-PEG, grafting MAL-PEG-BIOTIN to 
the US-responsive copolymer PUSL obtained by RAFT. Then, 
this polymer containing biotin was reacted with MSNs to 
obtain HYBRIDL-PEG-BIOTIN, in a similar way as described 
above. In this case, half of the polymer chains had the moiety 
of interest, while the other half were PUS-PEG chains without 
further modification. 
Synthesis of RGD-targeted nanoparticles. 
The synthesis of the material HYBRIDL-PEG-RGD was carried 
out in two steps: First, we prepared the hybrid containing 
DBCO moieties (HYBRIDL-PEG-DBCO), which was then reacted 
with an azide-functionalized peptide containing the RGD 
sequence: N3-Lys-Cys-Arg-Gly-Asp-Arg (RGD-N3). 
HYBRIDL-PEG-DBCO: The polymer dibenzocyclooctyne-
polyethilenglicol-maleimide, MAL-PEG-DBCO, was synthesized 
as follows (Scheme 1): 14 mg of DBCO-amine derivate were 
dissolved in the minimum amount possible of methylene 
chloride anhydrous. Under inert atmosphere, 10 µL of DIPEA 
were added and the mixture was stirred 30 minutes at room 
temperature (solution A). On the other hand, 40 mg of MAL-
PEG-NHS were also dissolved in the minimum amount of 
dichloromethane under nitrogen atmosphere (solution B). 
Solution A was added dropwise over solution B and the 
resulted mixture was stirred overnight at 40 ºC. The methylene 
chloride was removed under vacuum and the resulting crude 
was purified by silica flash column chromatography using 
DCM:MeOH (30:1) as eluent. The final product was 
characterized by 
1
H NMR, and the spectrum can be found in 
Figure S1. 
Then, PUSL-PEG-DBCO was synthesized in a similar way as 
described for PUSL-PEG-BIOTIN, by grafting the synthesized 
MAL-PEG-DBCO to the US-responsive copolymer PUSL 
obtained by RAFT. This PUSL-PEG-DBCO was reacted with 
MSNs to obtain the HYBRIDL-PEG-DBCO similarly as described 
for the preparation of the hybrid containing biotin.  
HYBRIDL-PEG-RGD: Initially, the peptide RGD-N3 was 
synthetized following the standard solid-phase techniques 
using Fmoc-coupling chemistry (Scheme S2). Amino acids were 
added sequentially to build the peptide sequence on a solid 
resin. After the coupling of each amino acid, the solid resin 
was washed and deprotection of the last amino acid 
incorporated was performed to allow the coupling of the next 
one. The final functionalized Wang resin was treated with 
TFA/TIPS/H2O cleavage cocktail in order to afford a peptide 
crude that was purified by G-25 Sephadex column size 
exclusion chromatography. 
1
H NMR spectrum can be found in 
Figure S2. 
To obtain RGD-modified particles, HYBRIDL-PEG-RGD, 4 mg of 
HYBRIDL-PEG-DBCO nanoparticles were reacted with RGD-N3 
(2 mg) in water at 4 ºC under magnetic stirring overnight. 
Then, the nanoparticles were collected by centrifugation and 
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washed once with cold water and twice with preheated PBS 
(37 ºC).  
Cargo loading and release. 
Fluorescein loading was performed by dispersing the HYBRID-
PEG material (10 mg) in a solution of fluorescein (100 mg) in 
PBS (5 mL) and stirring overnight at 4 ºC, since the polymeric 
gate will be open at that temperature. The medium was then 
heated to 37 ºC and the particles were collected by 
centrifugation. The loaded nanoparticles were extensively 
washed with PBS at 37 ºC.  
Doxorubicin loading was performed in a similar way using 
RGD-targeted nanoparticles: 4 mg of HYBRIDL-PEG-RGD were 
loaded with doxorubicin in 2.5 mL of PBS containing 1 mg/mL 
of the drug at 4 ºC overnight. 
Release experiments were performed as follows: Fluorescein-
loaded materials dispersed in PBS were exposed to a 
commercial laboratory ultrasound device before starting the 
experiment (1.3 MHz, 100 W, 10 min, continuous wave (CW), 
conditions used in our previous work).
24
 The experiment was 
carried out placing aliquots of suspensions of the loaded 
material in 12 well plate Transwell inserts (0.5 mL per insert), 
and adding 1.5 mL PBS to the outer volume of the well. At each 
time point, the external volume was collected and analyzed, 
and the well was filled with 1.5 mL of fresh PBS (to ensure sink 
conditions). The samples were measured by fluorimetry to 
determine the amount of fluorescein released (λEx: 490 nm; 
λEm: 514 nm). Same procedure was carried out with samples 
without US exposure. 
Cell culture experiments. 
Cell culture experiments with HeLa cells were carried out to 
evaluate nanoparticle uptake by the cells, as well as cell 
viability when incubated with drug-loaded nanoparticles. HeLa 
cells were seeded in 24 well plates at a density of 20,000 cells 
per cm
2
 24 h before the experiments were performed. 
For the nanoparticle uptake experiments, cells were incubated 
with 200 µg/mL suspension of the nanoparticles (with or 
without the targeting moiety) in complete culture medium 
(DMEM with 10% FBS). The particles were incubated with the 
cells overnight, and then they were removed and the cells 
were washed with PBS to remove non-internalized 
nanoparticles. Cellular uptake was evaluated by fluorescence 
microscopy and flow cytometry. For the fluorescence 
microscopy experiments, cells were fixed with methanol 
containing 1 µg/mL DAPI to stain the cell nuclei, followed by 
three washing steps with PBS. Flow cytometry experiments 
were performed in 0.5 % trypan blue (in PBS) to remove any 
extracellular fluorescence due to non-internalized 
nanoparticles. 
For the cytotoxicity experiment, RGD-targeted nanoparticles 
(HYBRIDL-PEG-RGD), loaded with doxorubicin were incubated 
with the cells overnight (100 µg/mL suspension). Then, the 
cells were rinsed with PBS, and half of the wells were exposed 
to ultrasound (using a physiotherapy device, New Pocket 
Sonovit, New Age Italia Srl, Italy) from the top of the well 
totally filled with culture medium (1 MHz, 3 W/cm
2
, 5 min, 
CW). The cells were then further incubated with 1 mL of 
complete culture medium per well. At different time points, 
cell viability was evaluated by Alamar Blue assay (Promega, 
Spain) following the manufacturer’s instructions. 
Results and Discussion 
PEGylated Ultrasound-Responsive system 
Recently, we have developed an ultrasound-responsive hybrid 
Mesoporous Silica Nanocarrier (HYBRID) capable of inducing 
cargo release when exposed to high frequency ultrasound.
24
 
That material was obtained by grafting a thermo-and 
ultrasound-responsive random copolymer, p(MEO2MA-co-
THPMA), to the surface of MCM 41-type MSNs. Before 
ultrasound exposure, the copolymer shows an LCST lower than 
37 ºC, so the polymer will be collapsed on the nanoparticle 
surface, capping the pore entrances and avoiding premature 
release of the cargo. Upon US exposure, the US-sensitive 
monomer THPMA will be cleaved, giving rise to hydrophilic 
methacrylic acid. This will induce an increase in the LCST of the 
polymer, which will irreversibly change to a coil-like 
conformation, opening the pore outlets and inducing cargo 
release at physiological temperature.
24,30
 
However, that proof-of-concept material presents several 
problems when considering an in vivo scenario. First, the 
polymeric gate closes the pore entrances of the material when 
collapsing on its surface due to the thermoresponsive behavior 
of the polymer.
24
 This implies that, when the material is 
closed, the surface is highly hydrophobic and the particles 
would therefore be likely to aggregate. Second, this material 
also lacks of any type of active targeting moieties, which are 
thought to be of great importance for the efficacy of 
nanotherapeutics.
4
 Both problems could be potentially 
addressed by the attachment of PEG chains with a targeting 
agent to the exposed end of the polymer. The aim of this work 
is to adapt the proof-of-concept material previously reported 
to a more useful platform, PEGylated and actively targeted. 
However, the chemical strategies employed in our previous 
work would not enable to carry out this modification in an 
easy fashion, so novel methods need to be explored. 
A bifunctional US-responsive copolymer must be obtained to 
be able to attach a PEG molecule to it. That way, one 
functional end will be used to graft a PEG chain while the other 
one will be attached to the nanoparticle surface. The polymer 
described in our previous work,
24
 which was obtained by Free 
Radical Polymerization (FRP), only presented one functional 
end, with a carboxylic acid provided by the initiator ABCVA. An 
US responsive copolymer with two different functional ends 
(PUS) has been here obtained changing the synthetic 
procedure from FRP to Reversible Addition-Fragmentation 
Chain Transfer (RAFT) polymerization by using a 
trithiocarbonate RAFT agent (CDTPA) that also presents a 
carboxylic acid (Figure 1). The monomer ratio was kept at 
90:10 (MEO2MA:THPMA) according to our previous results.
24
 
1
H NMR spectra (Figure S3) confirmed the correct synthesis of 
the desired copolymers. 
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Figure 1. Structure of the obtained US-responsive polymer, PUS, obtained by RAFT 
polymerization. 
US-Responsive copolymers, PUS, with different molecular 
weights (Mn) were obtained (PUSS, PUSM and PUSL) by 
modifying the monomers/RAFT agent ratio,
31
 as shown in 
Table 1. This allowed us to evaluate the effect of the molecular 
weight of the polymeric gate on the behavior of the final 
material.  
 
Table 1. GPC data of the different PUS obtained in this work before and after coupling 
with MAL-PEG-OMe (PUS-PEG) 
PUS 
sample 
Mn 
(Da) 
PDI  PUS-PEG 
sample 
Mn 
(Da) 
PDI  PEG Mn 
(Da) 
PUSS 25624 1.19 PUSS-PEG 26599 1.22 2000 
PUSM 46776 1.56 PUSM-PEG 51880 1.68 5000 
PUSL 67030 1.63 PUSL-PEG 73061 1.78 5000 
 
The aminolysis of the trithiocarbonate was carried out in the 
presence of a maleimide-modified PEG to graft it to the above 
RAFT copolymers. A one-pot thiol-ene click reaction took 
place, coupling the PEG chain to our US-responsive 
copolymers,
29
 obtaining PUS-PEG polymers (Scheme 1) with 
different molecular weights (Table 1). 
 
 
 
 
 
 
 
 
 
Scheme 1. Representation of the synthetic procedure employed to obtain PUS-PEG. 
After purification, the 
1
H NMR spectra of the obtained 
copolymers (Figure S3) confirms the PEG grafting (signal 
between 3.6 and 3.7 ppm). Table 1 shows an increase in the 
molecular weight of the copolymers after the PEGylation 
process in the same range as the molecular weights of the PEG 
chains being grafted. Furthermore, the absence of smaller 
polymer chains in the GPC chromatograms (data not shown) 
confirms the purification of the PEGylated copolymers from 
unreacted PEG chains. 
The US-responsiveness of the copolymer after conjugation 
with PEG was checked by monitoring the LCST behavior before 
and after ultrasound exposure. The results show that our PUS-
PEG presents a LCST below 37 ºC in water before the 
application of US (Figure 2). This behavior implies that at 
physiological temperature the polymer will be collapsed on the 
nanoparticle surface, effectively capping the pores and 
preventing the premature release of the drug. After US 
application, the LCST is shifted to values above 45 ºC. This 
change is due to the cleavage of the hydrophobic THPMA and 
its conversion to hydrophilic methacrylic acid, which induces a 
change in the overall hydrophilicity of the p(MEO2MA-co-
THPMA) block, displacing the LCST to a higher temperature.
24
 
The US-responsiveness of PUS-PEG was independent of its 
molecular weight (data not shown). This US-responsive 
behavior will provide the induced release capability in the final 
hybrid material. 
Figure 2. Lower critical solution temperature (LCST) of PUSL-PEG before (blue) 
and after 10 min (red) of ultrasound application (1.3MHz, 100 W, CW). A 1 
mg/mL solution in water was used. 
 
Once the US-responsiveness of PUS-PEG had been shown, it 
was then conjugated with APTES through its carboxylic acid 
(via DCC/NHS chemistry) and grafted to the surface of MSNs by 
condensation with the silanol groups of the silica particle,
24
 as 
shown in Scheme 2.  
Thus, we obtained different PEGylated hybrid materials, 
HYBRID-PEG, as a function of the molecular weight of the PUS-
PEG grafted, as can be seen in Table 2. The organic matter 
percentage (determined by TGA) is similar (24-29 %) regardless 
of the molecular weight of the grafted polymer. However, 
significant differences can be found in the BET surface area, 
with decreasing values being obtained as the molecular weight 
of the polymers increased (Table 2, Figure S4).  
 
0
0.2
0.4
0.6
0.8
1
10 15 20 25 30 35 40 45
N
o
rm
a
li
ze
d
 S
ca
tt
e
ri
n
g
 I
n
te
n
si
ty
Temperature (ºC)
US
No US
Page 5 of 11 Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
11
 A
pr
il 
20
18
. D
ow
nl
oa
de
d 
by
 F
re
ie
 U
ni
ve
rs
ita
et
 B
er
lin
 o
n 
11
/0
4/
20
18
 1
6:
49
:0
9.
 
View Article Online
DOI: 10.1039/C8TB00444G
 This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 6  
Please do not adjust margins 
Please do not adjust margins 
Scheme 2. Synthetic procedure employed to obtain the PEGylated Ultrasound-responsive material, Hybrid-PEG. 
Table 2. Effect of molecular weight of the grafted copolymer on the organic matter %, 
BET surface area and % of dye released from HYBRID-PEG samples. 
Samples Organic 
matter % 
(TGA) 
BET 
surface 
area (m
2
/g) 
Pore 
volume 
(cm
3
/g) 
% Fluorescein 
released after 
20 h 
HYBRIDS-PEG 24.9 634 0.55 80 
HYBRIDM-PEG 24.0 585 0.39 45 
HYBRIDL-PEG 28.8 188 0.13 23 
 
The different HYBRID-PEG materials prepared were loaded 
with fluorescein. The percentage of dye released in PBS at 37 
ºC was measured after 20 h to test if the PEGylated US-
responsive polymers effectively block the pore entrances of 
the nanoparticles. Data collected in Table 2 indicates that the 
molecular weight of the RAFT polymer was found to be crucial 
on capping the pores to block premature cargo release. Thus, 
higher molecular weight led to less release of fluorescein. This 
result is in good agreement with previous work reported in the 
literature, showing that the molecular weight of polymers 
used as capping agents of MSNs drastically affects their 
efficiency.
32
 Longer polymer chains form larger aggregates 
when they collapse on the surface of the silica particle, acting 
as a more effective capping agent (Table 2). This is also in 
agreement with BET surface areas mentioned above for those 
same materials. It is worth noting that the Mn needed to 
effectively cap the pores in this work is significantly higher 
than what we had seen in our preceding paper (around 28000 
Da).
24
 
This different behavior can be explained by the change in the 
polymer synthetic method. RAFT polymerization allows a much 
better control over the polymerization reaction compared to 
to FRP.
33
 Thus, the molecular weight distribution of the 
copolymers obtained by RAFT polymerization was narrower 
than that obtained by FRP (PDI values around 2). Therefore, for 
the same Mn, the polymers obtained by FRP will present a 
significant percentage of polymer chains with a much larger 
size than the mean, which could have contributed to a better 
seal at the pore ends. According to these results, the hybrid 
material with the largest polymeric gate, HYBRIDL-PEG, was 
selected for all further experiments. 
Once HYBRIDL-PEG had been selected, a more extensive 
characterization of the material further confirmed the 
successful grafting of PUSL-PEG on the material surface. Figure 
3 shows the TEM micrographs of MSNs and HYBRIDL-PEG, 
where the highly ordered mesoporous structure of the 
nanoparticles can be observed. Those same TEM micrographs 
of HYBRIDL-PEG (Figure 3) show a phosphotungstic acid-
stained layer on the nanoparticle surface, which was not 
present on MSNs, corresponding to the polymeric gate, and 
confirming the successful grafting of the polymer to the 
nanoparticle surface. The FTIR spectrum of HYBRIDL-PEG 
(Figure 3) shows the typical bands of the polymer, between 
1400 and 1800 cm
-1
. The hydrodynamic diameter of HYBRIDL-
PEG obtained by DLS indicates a peak size of 250 nm, with Z 
potential values of -45 mV (hydrodynamic diameter of MSNs 
was 220 nm with a Z potential value of -21 mV). These data 
confirm the correct grafting of a PEGylated polymeric gate 
capable of blocking premature cargo release from the 
mesopores of the material at physiological temperature. 
 
Figure 3. Characterization of MSNs (left) and HYBRIDL-PEG (right). TEM micrographs 
showing polymeric coating stained with PTA (top), FTIR spectra of the materials 
(bottom). 
The stability of this new PEGylated hybrid material (HYBRIDL-
PEG) was compared with our previously reported non-
PEGylated hybrid material (HYBRID),
24
 using FITC-labeled 
nanoparticles (Figure 4). The particles were dispersed in PBS (1 
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mg/mL of nanoparticles) and kept at 37 ºC for 1 h without 
stirring,to be then evaluated under visible and ultraviolet (UV) 
light. HYBRID nanoparticles can be clearly observed at the 
bottom of the cuvette (better assessed by the fluorescence of 
nanoparticles under UV light), while HYBRIDL-PEG 
nanoparticles remain much better dispersed. This 
enhancement in nanoparticle suspension stability was further 
confirmed by evaluating the hydrodynamic diameter of the 
PEGylated and the non-PEGylated system after different 
periods of time in suspension in 1 mM PBS (Figure S5). Non-
PEGylated nanoparticles aggregated after 1 h in suspension, 
while the size of HYBRIDL-PEG remained unmodified for 6 h. 
These results indicate that the stability of the nanoparticle 
suspension was greatly improved in the PEGylated system, 
which was one of the main aims of our approach. Besides, 
PEGylation will extend nanoparticle circulation time after 
injection in vivo,
25,34
 due to a slower withdrawal from the 
circulation by organs from the Mononuclear phagocyte 
system. 
Figure 4. Suspension stability of HYBRID and HYBRIDL-PEG. Photographs taken under 
visible (left, center) or UV light (right). 
Finally, the US-responsiveness of HYBRIDL-PEG was evaluated 
performing fluorescein release experiments. The material 
should be capable of retaining the cargo at 37 ºC, and releasing 
it in response to the application of US as an external stimulus. 
Figure 5 shows that fluorescein release was greatly enhanced 
when US is applied on a loaded HYBRIDL-PEG suspension. 
These results indicate that the US-induced cargo release 
capability is retained in this PEGylated material, and its 
behavior is comparable to that obtained in our previous 
work.
24
 This US-responsive behavior would enable the cargo to 
be released mostly in the tumor environment, improving the 
safety and efficacy profile of the system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. In vitro fluorescein release from HYBRIDL-PEG without or with US exposure 
(10 min, 1.3 MHz, 100 W, CW). 
Targeted PEGylated Ultrasound-Responsive system 
Heretofore, we have successfully obtained a PEGylated 
material that can trigger the release of its cargo when exposed 
to US. However, no active targeting strategy had been 
implemented to enhance the specificity of this material. To 
address the need for active targeting molecules, a different 
hybrid material was obtained by a similar process, but 
employing a PEG chain with biotin at one end (as targeting 
agent) and a maleimide at the other end (as coupling moiety), 
MAL-PEG-BIOTIN (Scheme 3). Consequently, the biotin moiety 
will be present on the end of the PEG chain attached to the 
polymeric gate on the nanoparticle surface. Biotin, also known 
as vitamin B7, can be employed as an active targeting agent 
due to the overexpression of biotin receptors by a variety of 
cancer cells.
35
 While the TGA data did not allow us to estimate 
the amount of biotin in HYBRIDL-PEG-BIOTIN (Figure S4), such 
quantification was possible through the HABA/Avidin test. The 
value obtained (2.13 nmol biotin/mg of nanoparticles) was in 
close agreement with the value expected from the organic 
matter % (determined by TGA) and the Mn of the attached 
polymer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Synthetic procedure employed to obtain the PEGylated, biotin-targeted ultrasound-responsive material, HYBRIDL-PEG-BIOTIN. 
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An in vitro cellular uptake experiment was performed to test 
the efficacy of the biotin molecules exposed by our 
nanoparticles as active targeting agents. Incubation of non-
targeted and targeted PEGylated nanoparticles (HYBRIDL-PEG 
and HYBRIDL-PEG-BIOTIN) with HeLa cells, which have been 
reported to overexpress biotin receptors,
36
 shows a 
significantly increased cellular uptake of biotin-modified 
nanoparticles, as can be seen from fluorescence microscopy 
and flow cytometry data (Figure 6).  
These results confirm the possibility to attach a targeting 
moiety to the external surface of our US-responsive 
nanocarrier, allowing a selective delivery to specific types of 
cancer cells. However, the chemical strategies employed to 
obtain our final system, limit the amount of targeting agents 
that can be conjugated to the PEG chain before it is coupled 
with the polymeric gate and then grafted to the particles. Any 
molecule possessing free amines, carboxylic acids, thiols or 
maleimides can interfere with the subsequent reactions, giving 
rise to undesired side-products, and limiting the presented 
approach. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Uptake experiments in HeLa cells comparing HYBRIDL-PEG and HYBRIDL-
PEG-BIOTIN by fluorescence microscopy (top, showing cell nuclei in blue and 
nanoparticles in green) and flow cytometry (bottom). 
A modular device was designed to provide more versatility to 
our US-responsive system. Our approach consisted on 
conjugating a strained alkyne (the dibenzocyclooctyne or 
DBCO moiety) to a PEG molecule, which also presents a 
maleimide group in the other end, MAL-PEG-DBCO. This would 
allow carrying out the grafting process as already described 
(Scheme S1), and then coupling the desired targeting agent to 
the already prepared hybrid system, HYBRIDL-PEG-DBCO, by 
using a copper-free alkyne-azidecyclo addition. The DBCO 
moiety will react with azide-functionalized molecules to yield a 
stable triazole linkage. 
Before grafting any targeting molecules, a coupling reaction 
with an azide-dye (TAMRA-N3) was performed to ensure the 
presence and availability of the DBCO moiety in the material 
(Supporting Information). That way, sample color and/or 
fluorescence could be used to test if the click reaction has 
taken place. After reaction of HYBRID-PEG-DBCO with TAMRA-
N3, sample fluorescence indicates a successful reaction with 
the dye (Figure S6). Same results were obtained with the 
intermediate products (MAL-PEG-DBCO, PUSL-PEG-DBCO). This 
demonstrates the correct coupling of DBCO and that it is 
available to react through click chemistry. On the other hand, 
no reaction with the dye took place in the materials not 
carrying DBCO. All of these results indicate that it is possible to 
graft an azide-modified molecule to our HYBRIDL-PEG-DBCO. 
These data open the gate for endless easy modifications of the 
material, fine-tuning the targeting capacity of the system 
towards specific cell lines, once the US-responsive material has 
already been prepared. 
The versatility of this methodology has been tested by 
attaching a targeting agent to HYBRIDL-PEG-DBCO and 
evaluating its cellular uptake. A peptide containing the RGD 
(Arg-Gly-Asp) sequence was used as the active targeting agent 
to be anchored to HYBRIDL-PEG-DBCO. This sequence is 
selectively recognized by αvβ3 integrin receptor, and has been 
extensively studied as an active targeting agent for anticancer 
therapies.
37
 Several functional groups present in this sequence 
(like amines and carboxylic acids) would impede the inclusion 
of this peptide in the PEGylated polymeric gate, due to 
incompatibility issues with the polymer grafting methodology 
above described. For this reason, the RGD sequence was 
attached to HYBRIDL-PEG-DBCO by copper-free azide-alkyne 
cycloaddition using an azide-functionalized peptide, RGD-N3 
(Scheme S2) to obtain HYBRIDL-PEG-RGD (Figure 7). 
 
Figure 7. Structure of the obtained PEGylated RGD-targeted US-responsive hybrid 
mesoporous silica nanoparticles, HYBRIDL-PEG-RGD. 
Cellular uptake studies were carried out with HeLa cells, which 
also overexpress integrins capable of interacting with the RGD 
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sequence.
38
 Figure 8 shows a significantly increased uptake in 
RGD-containing nanoparticles (HYBRIDL-PEG-RGD). This result 
highlights the successful development of our modular strategy 
to obtain an actively-targeted material. Further, a competition 
assay with the addition of free RGD in the medium shows a 
decrease in the internalization of HYBRIDL-PEG-RGD, indicating 
a receptor-mediated uptake mechanism. 
 
Figure 8. Uptake experiments in HeLa cells comparing HYBRIDL-PEG and HYBRIDL-
PEG-RGD by fluorescence microscopy (top, showing cell nuclei in blue and 
nanoparticles in green) and flow cytometry (bottom). 
Finally, and since the material presented in this work is aimed 
for anticancer therapy, these actively-targeted nanoparticles 
must be able to kill cancer cells upon US exposure when 
loaded with a cytotoxic drug. According to the cellular uptake 
results, the targeted system (HYBRIDL-PEG-RGD) was selected 
for our cytotoxicity experiment with drug-loaded 
nanoparticles. Doxorubicin-loaded HYBRIDL-PEG-RGD 
nanoparticles were incubated with HeLa cells overnight. The 
cells were then washed with PBS to remove non-internalized 
nanoparticles, in order to try to only evaluate the effect on cell 
viability of nanoparticles that will release the drug within the 
cancer cell. Some of the cells were then exposed to ultrasound 
using a physiotherapy device, and cell viability was evaluated 
by Alamar Blue test over the next three days (Figure 9). 
Ultrasound itself was shown not to have any significant effect 
on cell viability. Ultrasound-exposed nanoparticles showed 
significantly higher cytotoxicity on HeLa cells than the 
nanoparticles not exposed to the stimulus, denoting the 
greater doxorubicin release upon US application. This further 
indicates that we have obtained a PEGylated, modularly-
targeted, ultrasound responsive drug carrier with great 
potential in the field of cancer nanomedicine. Nanoparticle 
uptake by the target cancer cells will be enhanced by the 
addition of an active targeting molecule, and the external 
application of ultrasound in the tumor area will induce the 
release of the cytotoxic drug loaded in the nanoparticle, killing 
the cancer cells while decreasing the undesired side effects of 
chemotherapy. 
 
Figure 9. Cytotoxicity assay measured by Alamar Blue test in HeLa cells at different time 
points (1, 2 and 4 days) after incubation with doxorubicin-loaded HYBRIDL-PEG-RGD. 
Samples without US exposure and with US exposure (1 MHz, 3 W/cm2, 5 min, CW) 
were evaluated (US was applied after measuring the 1 day time point). *p < 0.05 
(Student's t-test). 
Conclusions 
A PEGylated and targeted modular ultrasound-responsive 
nanocarrier based on Mesoporous Silica Nanoparticles has 
been successfully obtained. To prepare this material, we had 
to develop a new set of chemical strategies, since previously 
reported methods were not suitable to afford this versatile 
stimulus-responsive nanocarrier. 
First, a non-targeted PEGylated material possessing 
ultrasound-promoted cargo release was obtained and 
characterized. That PEGylated material showed increased 
stability in aqueous suspension when compared to its non-
PEGylated control, which is of great interest for its biomedical 
application.  
By further modifying the material, a modular nanocarrier was 
obtained, in which any targeting agent could be easily 
attached to the final system through click chemistry. By taking 
advantage of that modularity of the material, RGD-decorated 
nanoparticles were obtained and demonstrated to induce 
enhanced cellular uptake. Drug-loaded RGD-targeted 
PEGylated nanoparticles were shown to produce significantly 
increased cancer cell killing when exposed to ultrasound. 
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A modularly-targeted, PEGylated and ultrasound-responsive hybrid nanomaterial is here 
prepared. Starting from naked mesoporous silica nanoparticles, we describe the synthetic 
method to obtain this hybrid material, also carrying out its characterization and in vitro 
evaluation. 
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